Answers are grounded in this paper and cite their sources.
To describe the first successful treatment of concomitant Myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR-T cells.
No takes yet. Share an insight, caveat, or question.
Motte et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: